ADHD drugs and cardiovascular risk

N Engl J Med. 2006 Apr 6;354(14):1445-8. doi: 10.1056/NEJMp068049. Epub 2006 Mar 20.
No abstract available

MeSH terms

  • Adult
  • Appetite Depressants / adverse effects
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Cardiovascular Diseases / chemically induced*
  • Central Nervous System Stimulants / adverse effects*
  • Central Nervous System Stimulants / therapeutic use
  • Child
  • Death, Sudden / etiology
  • Drug and Narcotic Control*
  • Ephedra / adverse effects
  • Female
  • Humans
  • Male
  • Phenylpropanolamine / adverse effects
  • Sympathomimetics / adverse effects*
  • Sympathomimetics / chemistry
  • United States
  • United States Food and Drug Administration

Substances

  • Appetite Depressants
  • Central Nervous System Stimulants
  • Sympathomimetics
  • Phenylpropanolamine